Stay updated on Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.

Latest updates to the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPublications now indicate that PubMed entries are automatically filled in from PubMed and may not relate to the study, and the revision label was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedA government funding operating status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedNo additions or deletions are visible on the Study Details page. The content continues to present the Pembrolizumab +/- Bevacizumab for Recurrent GBM study details.SummaryDifference0.3%

- Check71 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check78 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page has been updated to revision v3.0.2, replacing the previous v3.0.1, and the Back to Top control has been removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.